TRENDS IN IP DISPUTES

Similar documents
Panel on IP Valuation: How Much is it Worth? How Much Can You Get? How Can You Protect It?

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC

Larry R. Laycock. Education. Practice Focus. Attorney at Law Shareholder

US Patent Litigation Trends in Cloud Computing IPlytics GmbH

Programs for Academic and. Research Institutions

IN THE SUPERIOR COURT OF NEW JERSEY LAW DIVISION, MIDDLESEX COUNTY

John D. Denkenberger Co-Managing Member Chair of Litigation Group

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K

October 4 6, Session IX. The legal Problems arising from Auctioning of IPRs. Saturday, October 6, to p.m.

Baldassare Vinti is a partner in the Patent Law and Intellectual Property Groups.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Managing IP Assets Throughout the. Patent Lifecycle

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Partner 2323 VICTORY AVENUE SUITE 700 DALLAS, TX T F

MR. SCOTT A. BARNES, CPA, CFF, CGMA

R. Cameron Garrison. Managing Partner

TAKE 5 ON PATENTS. and Trademark Office is increasing every year, with over 18,000 issuing in January 2015 according

1 of 5 5/11/16 10:13 AM

Bloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs

The Objective Valuation of Non-Traded IP. Jonathan D. Putnam

Life Sciences IP Report

Intellectual Property

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Jeffrey S. Sharp Managing Partner

Daryn A. Grossman. Proskauer.com. Partner. New York

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

University joins Industry: IP Department. Georgina Marjanet Ferrer International, SA

New York Bar admission (or eligibility to obtain admission promptly) is required.

Intellectual Property

The Uneasy Future of Software and Business-Method Patents

European Patent Reform Forum USA December , New York

Davé Law Group s Unique Value Proposition

1004: Corporate Communications and Attorney-Client Privilege: What You Need to Know

Batya F. Forsyth Partner

Litigators for Innovators

Robert S. Harrell, Head of Financial Institutions and Insurance,...

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Patent. Fish &Richardson

Paul E. Burns, Partner

The 2011 EU industrial R&D investment SCOREBOARD

THE LEGAL MARKETPLACE IN AN EVOLVING PATENT LANDSCAPE

YOU CREATE. YOU INNOVATE. WE PROTECT.

Firm Overview. The firm includes 25 professionals, including 19 lawyers and 6 patent agents and technical specialists, of whom 10 hold Ph.D. degrees.

William E. Solander. Case Highlight

Intellectual Property Litigation

Method of Declaration. Hospitality/Interest/Sponsorship

Patent Assertion Entity Activity: An FTC Study

David I. Greenbaum Partner

Hamilton Loeb. Washington, D.C. Practice Areas. Admissions. Languages. Education. Partner, Litigation Department

Geoffrey L. Oberhaus Partner

Charles S. Barquist SENIOR COUNSEL EDUCATION BAR ADMISSIONS CLERKSHIPS PRACTICES

Eyal H. Barash. Employment Jan Current

Case5:11-cv LHK Document1082 Filed05/08/15 Page1 of 5

Bas de Blank. Representative Engagements. Partner Silicon Valley T E

Eric J. Marandett. Practice Group Leader PRACTICE FOCUS. T +1 (617)

Sapna W. Palla. New York:

How To Draft Patents For Future Portfolio Growth

Early Valuation. Company Portfolio

The EX ANTE DEBATE. Presented by. Monica M. Barone Sr. Legal Counsel Qualcomm. Monica M. Barone Sr. Legal Counsel Qualcomm

Getting the Most From Your IP Budget: Strategies for IP Portfolio Management and Litigation Avoidance

2017 Author Biographies

Tiffany D. Gehrke. Associate. Tel

Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences. March 1, 2007 Council for Science and Technology Policy

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models

François G. Laugier's Representative Experience

Observations from Pharma

Case 5:07-cv D Document 1 Filed 06/06/07 Page 1 of 11 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF OKLAHOMA

Protect Your Innovation and Maximize Your Investment Return in Automotive Electronics

Commercialization of Intellectual Property by Universities and Academic Institutions in the United States: Sample Agreements and Secondary Sources

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

Nokia Technologies in 2016 Technology to move us forward.

Intellectual Capital in Enterprise Success

POST EVENT REPORT IP Life Sciences Exchange 2015

Trademarks. Fortune 500 companies and organizations of all sizes trust Lathrop Gage to help establish, guard, maintain and enforce trademarks.

2013 IPO Corporate IP Management Benchmarking Survey Results AUGUST 2013

THE AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION RECOMMENDATIONS REGARDING QUALIFICATIONS FOR

11th Annual Patent Law Institute

Patent Masters Symposium A part of the IPWatchdog Institute

Ryan N. Phelan. Tel

Engr. VIRGINIA F. AUMENTADO Patent Information Analytics and Technology Monitoring Division (PATMD)

WIPO LIST OF NEUTRALS BIOGRAPHICAL DATA

Key Strategies for Your IP Portfolio

EDUCATION. Our Clients

Intellectual Property

Patent Assertion Entity Activity: An FTC Study

David C. Doyle PARTNER EDUCATION BAR ADMISSIONS PRACTICES

IP Attorneys Dominate At Fish & Richardson

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box Wellesley, MA

Karen K. Gaunt Partner

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Patent Prosecution & Strategic Patent Counseling

Issues and Possible Reforms in the U.S. Patent System

Pharmaceutical Sector Inquiry Presentation of the Preliminary Report. 28 November 2008

PATENTESQUE LAW GROUP, LLP

RUTHANN G. ZIEGLER. Ruthann G. Ziegler Principal. 555 Capitol Mall, Suite 1200 Sacramento, CA 95814

GORODISSKY & PARTNERS

New Emphasis on the Analytical Approach of Apportionment In Determination of a Reasonable Royalty

Transcription:

ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1

AGENDA Patent infringement and IPR filing trends Operating Companies in infringement cases Counterparties to Operating companies ND California New damage rules 2

PATENT INFRINGEMENT AND IPR FILING TRENDS 3

DISTRICT COURT AND IPR FILINGS Source: Patexia 4

DISTRICT COURT FILINGS Source: Patexia 5

IPR FILINGS Source: Patexia 6

OPERATING COMPANIES IN INFRINGEMENT CASES 7

OPERATING COMPANIES IN MORE THAN 7 NEW CASES 1/1/16 TO 3/31/17 8

CASES FILED BY DISTRICT 9

COMPUTERS AND DEVICES 10

BRANDED PHARMACEUTICALS Company Category Plaintiff Defendant Total sanofi aventis US LLC Pharmaceuticals Branded 31 0 31 Eli Lilly and Company Pharmaceuticals Branded 29 0 29 Genzyme Corporation Pharmaceuticals Branded 28 0 28 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals Branded 19 0 19 Amgen Inc. Pharmaceuticals Branded 16 2 18 AstraZeneca AB Pharmaceuticals Branded 16 1 17 Pfizer Inc. Pharmaceuticals Branded 11 3 14 Astellas Pharma Inc. Pharmaceuticals Branded 11 0 11 Alcon Research, Ltd. Pharmaceuticals Branded 10 2 12 Horizon Pharma USA, Inc. Pharmaceuticals Branded 11 0 11 Merck Sharp & Dohme Corp. Pharmaceuticals Branded 7 2 9 11

GENERIC PHARMACEUTICALS 12

SOFTWARE / E-COMMERCE 13

TELECOMMUNICATIONS AND WEARABLES 14

ALL OTHER Company Category Plaintiff Defendant Total Whirlpool Corporation All Other 28 2 30 Lighting Science Group Corporation All Other 18 0 18 Broadcom Corporation All Other 8 8 16 Nichia Corporation All Other 13 0 13 O.F. Mossberg & Sons, Inc. All Other 13 0 13 Intel Corporation All Other 1 11 12 Interlink Products International, Inc. All Other 11 0 11 Ninebot (Tianjin) Technology Co., Ltd. All Other 9 2 11 Segway Inc. All Other 9 2 11 Akeso Health Sciences, LLC All Other 9 2 11 PetEdge, Inc. All Other 7 1 8 Boston Scientific Corporation All Other 5 3 8 Galderma Laboratories, LP All Other 8 0 8 BMW of North America, LLC All Other 2 6 8 15

COUNTER PARTIES TO OPERATING COMPANIES 16

COUNTER PARTIES TO 100 OPERATING COMPANIES WITH MORE THAN 6 CASES FILED 17

ND CALIFORNIA NEW DAMAGE RULES 18

THE NORTHERN DISTRICT AMENDS ITS LOCAL RULES- TO REQUIRE EARLY DAMAGES-RELATED DISCLOSURES http://blogs.orrick.com/norcal-ip/2017/02/09/full-disclosure-the-northern-district-amends-its-local-rules-to-require-early-damages-related-disclosures/ 19

DAVID YURKERWICH Managing Director and the Leader of the Navigant s Intellectual Property team. Operates from offices in New York, San Francisco and Germany. Navigant IP s team of seasoned experts assist clients with IP strategy, transactions and disputes. They combine timely competitive data with analytical tools to deliver sound valuations and practical business solutions. David works closely with inventors, owners and attorneys to assess patentability and markets for technologies to build and maintain competitive patent portfolios. He actively negotiates IP based transactions and structures and manages joint development, and licensing activities. David has provided expert valuation testimony in over 90 matters involving IP and other disputes in a broad range of technologies and markets. David has been recognized by his peer group as one of the IAM Strategy 300 The World s Leading IP Strategists since its inception in 2008. david.yurkerwich@navigant.com +1 917-860-5151 20